project id: TCGA-BLCA; case submitter id: TCGA-DK-AA6L; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.79; rna integrity number: 8.2; age at index: 48; days to birth: -17635; days to death: 1163; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1962; year of death: 2013; age at diagnosis: 17635; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.1; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Dome of bladder; synchronous malignancy: Not Reported; tissue or organ of origin: Dome of bladder; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; cigarettes per day: 40.0; pack years smoked: 730.0; is ffpe: false; composition: Not Reported; days to collection: 1418; sample id: 86cfbaf2-9db7-479e-964e-f3e69cd1dd7c; sample submitter id: TCGA-DK-AA6L-01A; portion id: 50e939d2-843b-47e5-9c91-6b5732b3f929; portion submitter id: TCGA-DK-AA6L-01A-11; slide id: 5794f0c6-9ed6-489a-9621-18ccc5935548; slide submitter id: TCGA-DK-AA6L-01A-01-TSA; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 65.0; section location: TOP;